BSE filing, BSE: 544667. Summary written from the filing by ALFA Finder's alert engine.
Dachepalli Publishers Ltd: key numbers
- Share price
- ₹91.05
- Market cap
- ₹136.4 Cr
- Revenue (annual)
- ₹91.36 Cr
- Net profit (annual)
- ₹15.20 Cr
- P/E (TTM)
- 9.0×Sector 46.5×
- Promoter holding
- 64.78%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dachepalli Publishers Ltd
All →Dachepalli Publishers Other Announcement
Dachepalli Publishers filed its auditor's review report on the unaudited half-year results to 30 Sept 2026. No P&L table or monetary figures appear in the filed pages.
Dachepalli Publishers Earnings Call Transcript: Key Takeaways
Dachepalli Publishers reported strong 74% revenue growth in H1 FY27, yet faced margin pressure from rising raw material costs and aggressive marketing spend.
- Call
- Guides 65% growth
Dachepalli Publishers Investor Presentation: Key Takeaways
H1 FY27: revenue ₹70.06 Cr (+73.6%), EBITDA ₹14.63 Cr, PAT ₹9.71 Cr (+28.5%). Backward integration into notebook manufacturing; Hara Communications acquisition pending approvals.
Dachepalli Publishers Results Update
Dachepalli Publishers reported H1 FY27 income of ₹70.06 Crore, up 74% YoY. The company commenced in-house notebook manufacturing and launched its PageCraft brand.
Dachepalli Publishers H1 FY27 Results: Net Profit ₹9.7 Cr, Up 27.6% YoY
Dachepalli Publishers Ltd reported revenue from operations of ₹70 Cr (+73.3% YoY) and net profit of ₹9.7 Cr (+27.6% YoY) for H1 FY27.
- Key figure
- Net profit ₹9.7 Cr · +27.6% YoY
Dachepalli Publishers Board Meeting Date
Dachepalli Publishers has scheduled a board meeting for October 24, 2026, to consider and approve its un-audited financial results for the half-year ended September 30, 2026.
Other merger & restructuring announcements
All →Narayana Hrudayalaya Merger & Restructuring
Narayana Hrudayalaya's NCLT Bengaluru bench sanctioned the demerger of clinical services from its subsidiary NH Integrated Care. Order uploaded today; effectiveness awaits certified copy filings.
Abans Enterprises Merger & Restructuring
Abans Enterprises' board approved voluntary liquidation of wholly owned subsidiary AGJT, subject to shareholder approval. Completion is expected within one year.
- Execution
- Expected within one year, subject to approvals and statutory formalities
Max Estates Merger & Restructuring Worth ₹0.01 Cr
Max Estates will subscribe to 10,000 shares worth ₹1 lakh in a yet-to-be-incorporated real estate company. The entity awaits Ministry of Corporate Affairs approval.
- Value
- ₹0.01 Cr
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Choice International Merger & Restructuring Worth ₹1.27 Cr
Choice International sold a unit or subsidiary to Arrowbridge Trade for Rs.1.275 Crore in cash. The buyer is unrelated and the deal is at arm's length.
- Value
- ₹1.27 Cr
Shringar House of Mangalsutra Merger & Restructuring Worth ₹5 Cr
Shringar House of Mangalsutra will incorporate a wholly owned jewellery subsidiary, subscribing Rs 5 Crore in cash. The subsidiary becomes a related party once formed.
- Value
- ₹5.00 Cr